Hussam Al-Deen Ashab
Overview
Explore the profile of Hussam Al-Deen Ashab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karnes R, Sharma V, Choeurng V, Ashab H, Erho N, Alshalalfa M, et al.
Clin Cancer Res
. 2018 May;
24(16):3908-3916.
PMID: 29760221
Currently, no genomic signature exists to distinguish men most likely to progress on adjuvant androgen deprivation therapy (ADT) after radical prostatectomy for high-risk prostate cancer. Here we develop and validate...
2.
Zhao S, Chang S, Spratt D, Erho N, Yu M, Ashab H, et al.
Lancet Oncol
. 2016 Oct;
17(11):1612-1620.
PMID: 27743920
Background: Postoperative radiotherapy has an important role in the treatment of prostate cancer, but personalised patient selection could improve outcomes and spare unnecessary toxicity. We aimed to develop and validate...
3.
Kim H, Alshalalfa M, Hoffman-Censits J, Lallas C, Davicioni E, Lin J, et al.
Urol Case Rep
. 2016 Oct;
9:51-54.
PMID: 27713863
Management of men with prostate cancer is fraught with uncertainty as physicians and patients balance efficacy with potential toxicity and diminished quality of life. Utilization of genomics as a prognostic...
4.
Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam L, et al.
Oncotarget
. 2016 Jul;
7(33):53362-53376.
PMID: 27438142
Standard clinicopathological variables are inadequate for optimal management of prostate cancer patients. While genomic classifiers have improved patient risk classification, the multifocality and heterogeneity of prostate cancer can confound pre-treatment...
5.
You S, Knudsen B, Erho N, Alshalalfa M, Takhar M, Ashab H, et al.
Cancer Res
. 2016 Jun;
76(17):4948-58.
PMID: 27302169
Prostate cancer is a biologically heterogeneous disease with variable molecular alterations underlying cancer initiation and progression. Despite recent advances in understanding prostate cancer heterogeneity, better methods for classification of prostate...
6.
Pesteie M, Abolmaesumi P, Ashab H, Lessoway V, Massey S, Gunka V, et al.
Int J Comput Assist Radiol Surg
. 2015 Jun;
10(6):901-12.
PMID: 26026697
Purpose: Injection therapy is a commonly used solution for back pain management. This procedure typically involves percutaneous insertion of a needle between or around the vertebrae, to deliver anesthetics near...
7.
Ashab H, Lessoway V, Khallaghi S, Cheng A, Rohling R, Abolmaesumi P
IEEE Trans Biomed Eng
. 2013 May;
60(9):2636-44.
PMID: 23674416
We propose an augmented reality system to identify lumbar vertebral levels to assist in spinal needle insertion for epidural anesthesia. These procedures require careful placement of a needle to ensure...
8.
Ashab H, Lessoway V, Khallaghi S, Cheng A, Rohling R, Abolmaesumi P
Annu Int Conf IEEE Eng Med Biol Soc
. 2013 Feb;
2012:2659-63.
PMID: 23366472
Purpose: Spinal needle injection procedures are used for anesthesia and analgesia, such as lumbar epidurals. These procedures require careful placement of a needle, both to ensure effective therapy delivery and...